Analysis PROPANC BIOPHARMA INC NEW (PPCBD)
5/30/2024
Analysis of PROPANC BIOPHARMA INC NEW (PPCBD)
Propanc Biopharma Inc (PPCBD) has shown some volatility in its stock price recently. The Relative Strength Index (RSI) is currently around 59.73, indicating that the stock is neither overbought nor oversold. The Moving Average Convergence Divergence (MACD) indicator is not available for the recent data points, so we cannot analyze the trend based on that.Looking at the price action, we can see that the stock has been fluctuating between a low of $0.0256 and a high of $0.098 in the past few days. The stock closed at $0.09 most recently.
The Moving Average (MA) indicator is showing an upward trend, with the Simple Moving Average (SMA) at $0.06562. The Exponential Moving Average (EMA) and Weighted Moving Average (WMA) are not available for some data points.
Overall, Propanc Biopharma Inc seems to be experiencing some price volatility, but the moving averages suggest a potential upward trend. Traders and investors may want to keep an eye on the stock for further developments.
Earnings
The company's results for the most recent quarter, ending on April 30, 2025, have not been provided at this time. The previous quarter's results, ending on February 27, 2025, were handled by the Transfer Agent. The quarter before that, ending on January 31, 2025, had results released after hours. The results for the quarter ending on October 31, 2024, were not provided at the time. However, for the quarter ending on August 1, 2024, the company reported an earnings per share (EPS) estimate of 1.32.Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits information for a specific company.In terms of financials, the company has strong operating cash flow and levered free cash flow, with a positive current ratio and a high total debt to equity ratio. The profit margin and operating margin are also healthy, indicating efficient operations. The company's fiscal year ends in September 2023, and the most recent quarter reported is March 2024. The company shows good returns on assets and equity.
Looking at stock statistics, the company has a low short ratio and a significant percentage of shares held by institutions. The stock price summary shows volatility with a beta of 1.264 and a 52-week change of 6.853%. The stock has a wide range between its 52-week low and high prices.
Valuation metrics reveal a high PEG ratio and price-to-book ratio, indicating potentially overvalued stock. The company's market capitalization and enterprise value are substantial, with moderate price-to-sales and enterprise-to-EBITDA ratios.
Lastly, dividends and splits information show a moderate payout ratio and dividend yield. The company has a history of dividends and stock splits, with upcoming dividend and ex-dividend dates provided.
Income statement 💸
These are the revenue figures. Here are the conclusions:1. The company's sales revenue has been increasing steadily over the years, from $274.5 billion in 2020 to $383.3 billion in 2023.
2. The gross profit margin has been relatively stable, with gross profit ranging from around $105 billion to $169 billion.
3. Operating income has also shown an increasing trend, reaching $114.3 billion in 2023 from $66.3 billion in 2020.
4. Net income has been growing consistently, with the company reporting a net income of $57.4 billion in 2020 and $97 billion in 2023.
5. Earnings per share (EPS) have shown a slight fluctuation but have generally increased over the years.
6. The company has been able to maintain a healthy EBITDA margin, with EBITDA reaching $129.2 billion in 2023.
7. Despite an increase in income tax expenses, the company has managed to improve its profitability over the years.
8. Overall, the financial performance of the company seems to be on a positive trajectory, with increasing revenues and profitability.
Balance Sheet
These are balance sheets. Here are the conclusions based on the data provided:1. Total assets have been increasing over the years, reaching $365,725,000,000 in 2018.
2. Current assets consist mainly of cash, inventory, and receivables, with a significant portion in short-term investments.
3. Non-current assets include investments, property, plant, and equipment, with a notable amount in machinery and furniture.
4. Total liabilities have also been on the rise, with the highest value recorded at $302,083,000,000 in 2022.
5. Current liabilities primarily comprise short-term debt, accounts payable, and other current liabilities.
6. Non-current liabilities include long-term debt and other non-current liabilities.
7. Shareholders' equity has shown fluctuations but generally increased over the years, with the highest value of $90,488,000,000 in 2019.
8. Common stock and retained earnings are the main components of shareholders' equity.
9. The company seems to be investing heavily in non-current assets, which could indicate growth and expansion strategies.
10. The company has been managing its short-term obligations effectively, as seen in the stable current ratio over the years.
Cash Flow 💶
This is the cash flow statement. Here are some conclusions we can draw from the data:1. The company's free cash flow has been fluctuating over the years, with the highest value in 2022 and the lowest in 2020.
2. Operating cash flow has been relatively stable over the years, indicating consistent operational performance.
3. Financing activities show significant changes, with large amounts being spent on common stock repurchase and dividends.
4. Investing activities also vary, with notable amounts being spent on the sale and purchase of investments.
5. The end cash position has been fluctuating, reaching its highest value in 2020 and its lowest in 2022.
6. Interest paid has increased over the years, indicating a higher cost of debt.
7. Income tax paid has also varied, with the highest amount paid in 2021.
8. The company has been issuing and repaying long-term debt, with varying amounts each year.
9. Stock-based compensation has also been changing, with the highest value in 2023.
10. Overall, the company's cash flow statement reflects fluctuations in financial activities and performance over the years.
Earnings estimate
Based on analysts' estimates for future quarterly and annual earnings per share:1. For the current quarter ending on June 30, 2024, the average EPS estimate is $1.33, with a low estimate of $1.27 and a high estimate of $1.36. This shows growth compared to the EPS of $1.26 from the same quarter a year ago.
2. For the next quarter ending on September 30, 2024, the average EPS estimate is $1.53, with a low estimate of $1.44 and a high estimate of $1.63. This indicates an increase from the EPS of $1.46 from the same quarter last year.
3. For the current fiscal year ending on September 30, 2024, the average EPS estimate is $6.59, with a low estimate of $6.43 and a high estimate of $6.92. This reflects growth compared to the EPS of $6.13 from the previous fiscal year.
4. Looking ahead to the next fiscal year ending on September 30, 2025, the average EPS estimate is $7.23, with a low estimate of $6.40 and a high estimate of $7.90. This suggests an increase from the EPS of $6.59 reported for the current fiscal year.
Overall, the analysts' estimates point towards a positive outlook for the company's earnings per share, showing growth in both the quarterly and annual periods.
Revenue estimate
Based on the analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:1. For the current quarter ending on June 30, 2024, the average sales estimate is $83,776,900,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 24.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $92,375,300,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 24.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $386,681,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 37.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $411,555,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 37.
These estimates suggest a moderate growth trend in both quarterly and annual sales for the company, with slightly higher growth expected in the next fiscal year compared to the current one.
Growth estimates
Based on the consensus estimates provided, we can draw the following conclusions regarding the growth rate of the company for different periods:1. Current Quarter: The estimated growth rate for the current quarter is 5.6%.
2. Next Quarter: The estimated growth rate for the next quarter is 4.8%.
3. Current Year: The estimated growth rate for the current year is 7.5%.
4. Next Year: The estimated growth rate for the next year is 9.7%.
5. Past 5 Years (per annum): The average annual growth rate for the past 5 years is 20.1%.
6. Next 5 Years (per annum): The estimated average annual growth rate for the next 5 years is 11%.
These estimates suggest a positive growth trend for the company, with a slightly lower growth rate expected in the next 5 years compared to the past 5 years. The company is projected to experience steady growth in the short term, with a more moderate but still healthy growth rate in the long term.
Price target
The analysts' forecast for the future price of the security paper is as follows:- Low: $164
- High: $250
- Median: $200
- Average: $202.26
- Current price: $191.57
- Currency: USD
Based on these forecasts, we can see that the analysts have a range of opinions on the future price of the security paper, with the low end at $164, the high end at $250, and the average at $202.26. The current price is below both the average and median forecast, indicating that there is potential for growth according to the analysts' predictions.
This is not investment advice. Remember to verify the information provided here.
Get access to the full analysis
- Over 35 000 indexes
- CFD, Forex, Crypto and Stocks Exchange
- Over 150 Indicators
- Pattern and candle analysis
- Support and resistance levels
- Fundamental, technical and sentimental analysis
- Power from AI
